1. Laboratory
  2. Laboratory medicine
  3. Rapid cancer test
  4. Pro-med (Beijing) Technology Co., Ltd.
video corpo

Oncology rapid test PMDOA
alpha-fetoproteinserumclinical

Oncology rapid test - PMDOA - Pro-med (Beijing) Technology Co., Ltd. - alpha-fetoprotein / serum / clinical
Oncology rapid test - PMDOA - Pro-med (Beijing) Technology Co., Ltd. - alpha-fetoprotein / serum / clinical
Oncology rapid test - PMDOA - Pro-med (Beijing) Technology Co., Ltd. - alpha-fetoprotein / serum / clinical - image - 2
Add to favorites
Compare this product
 

Characteristics

Applications
oncology
Tested parameter
alpha-fetoprotein
Sample type
serum, clinical
Result display time

10 min

Sample volume

0.02 ml
(0.00068 US fl oz)

Description

1 test/kit;5 tests/kit;10tests/kit;20tests/kit;25tests/kit; 30 tests/kit; 40 tests/kit; 50 tests/kit Clinical Significance:an important marker of liver cancer prognosis Performance Parameter:Sample:serum/plasma Linear range:3.0-2000.0ng/mL LOD:< 10.0ng/mL Applicable Department: Oncology department, physical examination Intended Use Serum alpha-fetoprotein(AFP)is a commonly used and important method for diagnosing primary hepatocellular carcinoma(HCC),and it is also one of the main methods ofliver cancer screening. When liver cells become cancerous, AFP is secreted and produced byliver cancer cells again, and about70% of liver cancer patients will have elevated alpha-fetoprotein in the serum, so alpha-fetoprotein has become a specific clinicalindicator for the diagnosis of primary liver cancer.

Catalogs

No catalogs are available for this product.

See all of Pro-med (Beijing) Technology Co., Ltd.‘s catalogs

Other Pro-med (Beijing) Technology Co., Ltd. products

POCT

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.